Back

Clinical determinants and long-term survival in heart failure with supra-normal ejection fraction. Insights from LECRA-HF registry.

14 March 2025 (17:20 - 18:20)
Organised by: Logo
Congress Presentation Part of: Improving outcomes in acute heart failure Epidemiology, Prognosis, Outcome ACVC Premium Access ESC Acute CardioVascular Care 2025 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Konrad Stepien

Jagiellonian University Medical College, John Paul II Hospital, Krakow (Poland)

8 More presentations in this session

Presentation thumbnail
Early predictors of in-hospital mortality in patients with acute heart failure. A general hospital experience
Doctor G. Aletras (Heraklion, GR)
Abstract Slides
Presentation thumbnail
Predictors of mortality in heart failure patients with reduced ejection fraction: neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio, neutrophil- percentage-to-albumin-ratio
Doctor J. Stevic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Genetic insights into cardiomyopathy: familial and histologic features of transplant-dependent failing hearts in hcmp
Doctor K. Kim (Incheon, KR)
Abstract Slides
Presentation thumbnail
Additional benefits ofSGLT2i therapy in patients with acute decompensated heart failure and central sleep apnea.
Assistant Professor P. Kalaydzhiev (Sofia, BG)
Abstract Slides
Presentation thumbnail
Current practices and perspectives on the use of intravenous vasodilators in acute heart failure: an international survey.
Doctor A. Galluzzo (Rivoli, IT)
Abstract Slides

Access the full session

Session thumbnail
Improving outcomes in acute heart failure

The Event

Event poster

ESC Acute CardioVascular Care 2025

14 March 2025 17:20 CET
You may be interested in
thumbnail
Congress Presentation
Long-term outcomes in heart failure with preserved ejection fraction: predictors of cardiovascular and non-cardiovascular mortality
30 June 2021
thumbnail
Congress Presentation
Phenotyping heart failure with a supranormal ejection fraction
23 May 2022
thumbnail
Congress Presentation
Getting to know the middle child
29 June 2021
thumbnail
Congress Presentation
Potential for delayed improvement of left ventricular ejection fraction in newly diagnosed heart failure under optimized therapy depends on etiology - data from the PROLONG-II study
3 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources